On Thursday, Depomed Inc (NASDAQ:DEPO)’s shares declined -4.20% to $30.53.
Depomed Inc (DEPO) declared it has reached a settlement agreement in its ongoing patent litigation related to an Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of Depomed’s Zipsor® (diclofenac liquid filled capsules) 25mg tablets. The settlement permits defendant Watson Laboratories Inc. to start selling generic Zipsor on March 24, 2022, or earlier under certain circumstances. The settlement concludes all ongoing ANDA litigation related to Zipsor.
The settlement agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, and entry of an order dismissing the litigation by the U.S. District Court for the District of New Jersey.
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the administration of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults.
NRG Energy Inc (NYSE:NRG)’s shares gained 2.31% to $22.36.
NRG Renew LLC, a wholly owned partner of NRG Energy, Inc. (NRG), the country’s largest independent power producer, declared plans to develop a 20 megawatt (MW) solar energy facility that will generate clean, reliable solar power for delivery to Cisco’s San Jose headquarters. NRG Renew LLC will convert its NRG Solar Blythe II location, which is a 153-acre parcel that has been under development by NRG since 2010, into a solar installation that will assist Cisco reach its aim of using renewable sources for at least 25 percent of its electricity needs by 2017. The project is planned to start commercial operation by the end of 2016.
Electricity generated by the solar installation will be sold to Cisco under a 20-year power purchase agreement (PPA), increasing Cisco headquarters’ total use of clean, emission-free electricity.
Located in the Sonoran Desert near the Arizona and California border, the NRG Solar Blythe II location receives plentiful sunshine: For nearly half the year, average temperatures reach 90°F or higher.1 The photovoltaic technology to be installed on-site requires no fuel and minimal water. The amount of emission-free energy generated is predictable to be equivalent to the power needed to serve more than 14,000 homes and to prevent more than 102,000 metric tons of carbon dioxide from entering the atmosphere annually, which is the equivalent of removing more than 21,000 cars from the road. During the construction period, the project is anticipated to create about 200 jobs.
NRG Energy, Inc., together with its auxiliaries, operates as a power company. The company provides electricity; system power, distributed generation, solar and wind products, backup generation, storage and distributed solar, demand response, energy efficiency, and on-site energy solutions; carbon administration and specialty services; and various energy services, such as operations, maintenance, technical, development, and asset administration services.
At the end of Thursday’s trade, Microchip Technology Inc. (NASDAQ:MCHP)‘s shares surged 0.33% to $42.91.
Microchip Technology Inc. (MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, declared that designers using the Automotive Open System Architecture (AUTOSAR) to develop and reuse their in-vehicle software can now connect their systems to not only networking technologies such as CAN and LIN, but also to the MOST® Cooperation’s automotive-proven MOST networking technology. This means that Microchip’s MOST Intelligent Network Interface Controllers (INICs) can be used for cross-domain communication in an AUTOSAR system, such as Advanced Driver Assistance Systems (ADAS), which simplifies automotive networking and diagnostics.
AUTOSAR has developed standardized, open software architecture for automotive electronic control units, which is increasingly being applied in traditional vehicle electronic domains. For example, after the major German vehicle OEMs successfully utilized AUTOSAR in the central areas of their electrical/electronics architectures, they are now extending its use into additional domains. With the introduction of the AUTOSAR 4.x standard, most other OEMs are now also investigating or actively migrating to AUTOSAR. Therefore, it is increasingly important that the infotainment domain of a vehicle is able to support AUTOSAR, at least where an interaction with other domains is necessary.
Microchip Technology Incorporated develops, manufactures, and sells semiconductor products for various embedded control applications. The company offers microcontrollers, such as 8-bit, 16-bit, and 32-bit microcontrollers under the PIC brand name; and 16-bit dsPIC digital signal controllers, in addition to provides microcontrollers for automotive networking, computing, lighting, power supplies, wireless communication, and wireless audio applications.
Nymox Pharmaceutical Corporation (NASDAQ:NYMX), ended its Thursday’s trading session with -3.68% loss, and closed at $2.62.
Nymox Pharmaceutical Corporation (NYMX) declare that the Company has newly designated James G. Robinson to the Board of Directors.
Mr. Robinson is a prominent and highly successful entrepreneur whose career spans multiple decades in the automotive and film industries with vast business experience in the areas of conception, administration, operations, distribution and marketing in both the U.S. and global markets.
For the past 28 years through Mr. Robinson’s initiative and astute leadership as Chairman and CEO, Morgan Creek has continued to prosper as one of the foremost independent film production companies. Morgan Creek has produced an assortment of highly successful and critically acclaimed features counting the Young Guns, Major League and Ace Ventura franchises, the award winning Enemies, A Love Story; and the blockbuster Robin Hood: Prince of Thieves. Later this year, production will start on the highly anticipated Tupac, the story of the rapper, actor and activist Tupac Shakur.
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. It offers NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products; and AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer’s disease.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
